Wednesday, June 24, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 888 of 1,261

  1. US 8361756

    Bifidobacterial gene sequences and their use

    The Regents of the University of California · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  2. US 8361958

    Oximyl HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  3. US 8361968

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  4. US 8362032

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  5. US 8362043

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  6. US 8362044

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  7. US 2013023524

    TRICYCLIC INDAZOLE COMPOUND, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING IT

    ACRAF [IT] · Granted Jan 24, 2013 · Expires Jan 19, 2033

    granted

  8. US 2013023492

    PHARMACEUTICAL COMPOSITIONS COMPRISING PLANT-BASED POLYSACCHARIDES AND USES THEREOF

    MARLOWE ZORA T [US] · Granted Jan 24, 2013 · Expires Jan 19, 2033

    granted

  9. EP 2548561

    Semuloparin zur Verbesserung der Überlebenschancen von Patienten mit örtlich fortgeschrittenem Krebs

    AVENTIS PHARMA SA [FR] · Granted Jan 23, 2013 · Expires Jan 18, 2033

    granted

  10. US 8357374

    Conjugates of synthetic TLR agonists and uses therefor

    The Regents of the University of California · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  11. US 8357361

    Bioabsorbable surgical composition

    Covidien LP · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  12. US 8357353

    Compositions comprising a UV-absorbing chromophore

    United States Department of Agriculture · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  13. US 8357379

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  14. US 8357365

    Granulysin peptides and methods of use thereof

    The Regents of the University of California · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  15. US 8357525

    Thermal inactivation of rotavirus

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  16. US 8357656

    Natriuretic peptide receptor-C agonists

    Regents of the University of Minnesota · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  17. US 8357702

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  18. US 8357534

    Isolation of human articular cartilage stem cells

    University College Cardiff Consultants Limited · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  19. US 8357371

    Methods for treating hypercholesterolemia using antibodies to PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  20. US 8357697

    Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  21. US 8357718

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  22. US 8357676

    Ansamycin formulations and methods of use thereof

    Infinity Discovery, Inc. · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  23. US 8357783

    Human anti-mesothelin monoclonal antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  24. US 8354436

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.